Hereditary haemochromatosis: Prevalence and characterization of the disease in a tertiary hospital in Aragon, Spain

被引:0
作者
Molina, Claudia Abadia [1 ]
Rosa, Nuria Goni [1 ]
Tarancon, Ricardo Gonzalez [2 ]
Varas, Luis Rello [1 ]
del Valle Recasens Flores, M. [3 ]
Alvarez, Silvia Izquierdo [2 ]
机构
[1] Hosp Univ Miguel Servet, Dept Clin Biochem, Zaragoza, Spain
[2] Hosp Univ Miguel Servet, Dept Clin Biochem, Genet Sect, Zaragoza, Spain
[3] Hosp Univ Miguel Servet, Dept Hematol & Hemotherapy, Zaragoza, Spain
来源
MEDICINA CLINICA | 2024年 / 163卷 / 09期
关键词
Haemochromatosis; Iron overload; Hyperferritinemia; Next-generation sequencing; Multiplex ligation-dependent probe; amplification; MUTATIONS; VARIANTS; ONSET; HFE;
D O I
10.1016/j.medcli.2024.05.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The main genetic cause of iron overload is haemochromatosis (HC). In recent years, the study of non-HFE genes (HFE2, HJV, HAMP, TRF2, SLC40A1, and BMP6) has become relevant thanks to nextgeneration sequencing (NGS) and multiplex ligation-dependent probe amplification (MLPA) techniques. Our objectives were to estimate the prevalence of both HFE (C282Y/HY63D variants) and non-HFE variants attending a tertiary hospital in Arag & oacute;n, to predict the effect of the variants on the protein, and to establish a genotype-phenotype correlation evaluating with the clinical context. Methods: Retrospective descriptive study from 2006 to 2020 of patients attended at genetic consultation in a reference hospital for HC in Aragon. We calculated prevalence of HFE and non-HFE variants. We analysed non-HFE genes (HFE2, HJV, HAMP, TRF2, SLC40A1, and BMP6), used bioinformatics tools, consulted different databases and measured clinical parameters (laboratory and imaging). Results: The prevalence of C282Y homozygous was 5.95% respect the total of cases and 0.025% respect our population. The prevalence of non-HFE HC variants was 1.94% respect the total of cases and 0.008% respect our population. We found 27 variants in non-HFE genes and 4 in HFE gene, of which 6 were classified as variant of uncertain clinical significance (VUS), or likely pathogenic or pathogenic according to the ACMG classification criteria. Conclusion: Our prevalence results are as expected, and similar to those obtained by other studies. Although some of the genetic findings explain the clinical symptoms of some of our patients, we remain have a high number of patients without a clear molecular diagnosis. (c) 2024 Elsevier Espana, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:442 / 448
页数:7
相关论文
共 27 条
  • [1] Haemochromatosis revisited
    Alvarenga, Aline Morgan
    Brissot, Pierre
    Santos, Paulo Caleb Junior Lima
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2022, 14 (11) : 1931 - 1939
  • [2] Revisiting hemochromatosis: genetic vs. phenotypic manifestations
    Anderson, Gregory J.
    Bardou-Jacquet, Edouard
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (08)
  • [3] Variable age of onset and clinical severity in transferrin receptor 2 related haemochromatosis: novel observations
    Bardou-Jacquet, Edouard
    Cunat, Severine
    Beaumont-Epinette, Marie-Pascale
    Kannengiesser, Caroline
    Causse, Xavier
    Sauvion, Sylvie
    Pouliquen, Bruno
    Deugnier, Yves
    David, Veronique
    Loreal, Olivier
    Aguilar-Martinez, Patricia
    Brissot, Pierre
    Jouanolle, Anne-marie
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2013, 162 (02) : 278 - 281
  • [4] Barque A., 2017, GENETICA MED Y GENOM, V1, P49
  • [5] Mutations and polymorphisms associated with iron overload in a series of 91 non-HFE haemochromatosis patients
    Borgel, Adrien
    Lamoril, Jerome
    Tchernitchko, Dimitri
    [J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2020, 44 (02) : 239 - 241
  • [6] What’s Important and New in Hemochromatosis?
    Pierre Brissot
    Eolia Brissot
    [J]. Clinical Hematology International, 2020, 2 (4) : 143 - 148
  • [7] Heterozygous Mutations in BMP6 Pro-peptide Lead to Inappropriate Hepcidin Synthesis and Moderate Iron Overload in Humans
    Daher, Raed
    Kannengiesser, Caroline
    Houamel, Dounia
    Lefebvre, Thibaud
    Bardou-Jacquet, Edouard
    Ducrot, Nicolas
    de Kerguenec, Caroline
    Jouanolle, Anne-Marie
    Robreau, Anne-Marie
    Oudin, Claire
    Le Gac, Gerald
    Moulouel, Boualem
    Loustaud-Ratti, Veronique
    Bedossa, Pierre
    Valla, Dominique
    Gouya, Laurent
    Beaumont, Carole
    Brissot, Pierre
    Puy, Herve
    Karim, Zoubida
    Tchernitchko, Dimitri
    [J]. GASTROENTEROLOGY, 2016, 150 (03) : 672 - +
  • [8] Next-generation sequencing of hereditary hemochromatosis-related genes: Novel likely pathogenic variants found in the Portuguese population
    Faria, Ricardo
    Silva, Bruno
    Silva, Catarina
    Loureiro, Pedro
    Queiroz, Ana
    Fraga, Sofia
    Esteves, Jorge
    Mendes, Diana
    Fleming, Rita
    Vieira, Luis
    Goncalves, Joao
    Faustino, Paula
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 2016, 61 : 10 - 15
  • [9] Early-onset haemochromatosis caused by a novel combination of TFR2 mutations(p.R396X/c.1538-2 A>G) in a woman of Italian descent
    Gerolami, V.
    Le Gac, G.
    Mercier, L.
    Nezri, M.
    Berge-Lefranc, J-L.
    Ferec, C.
    [J]. HAEMATOLOGICA, 2008, 93 (05) : E45 - E46
  • [10] Hemochromatosis classification: update and recommendations by the BIOIRON Society
    Girelli, Domenico
    Busti, Fabiana
    Brissot, Pierre
    Cabantchik, Ioav
    Muckenthaler, Martina U.
    Porto, Graca
    [J]. BLOOD, 2022, 139 (20) : 3018 - 3029